Pliant Therapeutics, Inc. (PLRX) a un PER historique négatif de -0.5, ce qui signifie que l'entreprise est actuellement non rentable sur la base des douze derniers mois (TTM). Le rendement bénéficiaire historique est de -183.67%.
Critères prouvés par cette page:
Score Global SharesGrow : 48/100 avec 2/7 critères réussis.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendement du Dividende |
|---|---|---|---|---|---|
| 2017 | -0.8 | 0.00 | 5.12 | 0.00 | - |
| 2018 | -11.6 | 0.13 | -398.71 | 0.00 | - |
| 2019 | -1,200.1 | 11.97 | -1,740.79 | 13.27 | - |
| 2020 | -19.4 | 0.00 | 2.85 | 19.32 | - |
| 2021 | -5.0 | -0.04 | 2.43 | 63.91 | - |
| 2022 | -6.6 | -0.78 | 2.59 | 83.86 | - |
| 2023 | -6.6 | 1.02 | 2.25 | 673.04 | - |
| 2024 | -3.8 | -0.14 | 2.62 | 0.00 | - |
| 2025 | -0.5 | 0.02 | 0.41 | 0.00 | - |
| Year | EPS (Dilué) | Chiffre d'Affaires | Résultat Net | Marge Nette |
|---|---|---|---|---|
| 2017 | $-25.67 | $0.00 | $-20.62M | - |
| 2018 | $-1.83 | $0.00 | $-30.28M | - |
| 2019 | $0.01 | $57.05M | $185K | 0.3% |
| 2020 | $-1.12 | $41.82M | $-39.75M | -95% |
| 2021 | $-0.50 | $7.57M | $-17.91M | -236.5% |
| 2022 | $-2.89 | $9.69M | $-121.5M | -1254.5% |
| 2023 | $-2.75 | $1.58M | $-161.34M | -10211.1% |
| 2024 | $-3.47 | $0.00 | $-210.3M | - |
| 2025 | $-2.43 | $0.00 | $-149.34M | - |
| Year | EPS (Moy.) | Fourchette EPS | CA (Moy.) | Fourchette CA | Analystes |
|---|---|---|---|---|---|
| 2026 | $-1.51 | $-1.78 – $-1.24 | $2.5M | $2.5M – $2.5M | 4 |
| 2027 | $-1.19 | $-1.53 – $-0.99 | $5M | $5M – $5M | 4 |
| 2028 | $-1.09 | $-2.05 – $-0.27 | $25M | $25M – $25M | 4 |
| 2029 | $-1.25 | $-1.25 – $-1.25 | $15M | $15M – $15M | 2 |
| 2030 | $-0.93 | $-0.93 – $-0.93 | $107.5M | $107.5M – $107.5M | 2 |
